NCT00429923View on ClinicalTrials.gov

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)

PHASE3CompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

Not specified

Conditions
Inflammation
Interventions
DRUG

Difluprednate

DRUG

Difluprednate

DRUG

Placebo

Trial Locations (1)

63090

Comprehensive Eye Care, Washington

All Listed Sponsors
lead

Sirion Therapeutics, Inc.

INDUSTRY

NCT00429923 - Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a) | Biotech Hunter | Biotech Hunter